Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Thoracic 3Gastrointestinal 3Gynecologic 2Tumor-Agnostic 1Genitourinary 1

Conditions

Lung Neoplasms 3

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Relaxation Therapy × Thoracic × Clear all
NCT05339022 2025-11-21

Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial

Ohio State University Comprehensive Cancer Center

Phase NA Completed
100 enrolled
Thoracic

Lung Neoplasms

NCT04229381 2023-11-15

ROAR-LCT

Ohio State University Comprehensive Cancer Center

Phase NA Completed
18 enrolled 9 charts
Thoracic

Lung Neoplasms

NCT02938104 2018-03-22

Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Completed
120 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡